HEFFTER BLOG

A recent article in Scientific American highlights the need to reform federal drug policy. In “Turn On, Tune In, Get Better: Psychedelic Drugs Hold Medical Promise,” writer Roni Jacobson describes how the FDA and DEA created a Catch-22 situation for scientists who study psychedelics. The...

Two upcoming conferences may be of interest to readers of this website. The World Ayahuasca Conference will be held from September 25th to the 27th in Ibiza, Spain. “The World Ayahuasca Conference 2014, organized by the ICEERS Foundation, aims to be a multidisciplinary event that brings together...

An article on the news site Vox features an in-depth interview with Heffter board member Dr. Charles Grob. “The Case for Medical LSD, Mushrooms, and Ecstasy,” by German Lopez, surveys the history and current status of psychedelic research. Dr. Grob discusses the potential of psychedelic...

An article by Kai Kupferschmidt in Science magazine gives a comprehensive survey of current psychedelic research. “High Hopes” focuses on the work of Heffter board member Stephen Ross and includes quotes from board members Roland Griffiths and Franz Vollenweider.“Albert Hofmann, the Swiss chemist who discovered...

An article in the New York Times “Fashion and Style” section covers the current popularity of the psychedelic beverage ayahuasca. The article features quotes from Heffter board member Charles Grob.“‘It”s a fascinating compound with a great deal to be learned from its effects,’ said Dr....